TARGETING OF MYC BY HDAC INHIBITION IN MYC AMPLIFIED GROUP 3 MEDULLOBLASTOMA

被引：0

作者：

Ecker, Jonas ^{[1
,2
,3
,4
]}

Oehme, Ina ^{[1
,2
]}

Selt, Florian ^{[1
,2
,3
,4
]}

Kool, Marcel ^{[2
,5
]}

Chavez, Lukas ^{[2
,5
]}

Hohloch, Juliane ^{[1
,2
]}

Valinciute, Gintvile ^{[1
,2
]}

van Tilburg, Cornelis M. ^{[3
,4
]}

Schnolzer, Martina ^{[6
]}

Warnken, Uwe ^{[6
]}

Wechsler-Reya, Robert ^{[7
]}

Pfister, Stefan M. ^{[2
,3
,4
,5
]}

Witt, Olaf ^{[1
,2
,3
,4
]}

Milde, Till ^{[1
,2
,3
,4
]}

机构：

[1] German Canc Res Ctr, Clin Cooperat Unit Pediat Oncol, Preclin Program, Hopp Childrens Canc Ctr,NCT KiTZ, Heidelberg, Germany

[2] German Canc Consortium DKTK, Heidelberg, Germany

[3] German Canc Res Ctr, Ctr Individualized Pediat Oncol ZIPO & Brain Tumo, Translat Program, Hopp Childrens Canc Ctr,NCT KiTZ, Heidelberg, Germany

[4] German Canc Co, Heidelberg, Germany

[5] German Canc Res Ctr, Div Pediat Neurooncol, Preclin Program, Hopp Childrens Canc Ctr,NCT KiTZ, Heidelberg, Germany

[6] German Canc Res Ctr, Funct Proteome Anal B100, Heidelberg, Germany

[7] Sanford Burnham Prebys Med Discovery Inst, Tumor Initiat & Maintenance Program, La Jolla, CA USA

来源：

NEURO-ONCOLOGY | 2017年 / 19卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

MEDU-20

引用

页码：41 / 42

页数：3

共 50 条

[21] LIPID SATURATION HOMEOSTASIS PRESENTS A TARGETABLE VULNERABILITY IN MYC-AMPLIFIED GROUP 3 MEDULLOBLASTOMA
Custers, Stefan
NEURO-ONCOLOGY, 2024, 26
[22] RESISTANCE MECHANISMS TO BET-BROMODOMAIN INHIBITION IN MYC-AMPLIFIED MEDULLOBLASTOMA
Bandopadhayay, Pratiti
Paolella, Brenton
O'Rourke, Ryan
Ho, Patricia
Greenwald, Noah
Sharpira, Ofer
Pantel, Sasha
Bagul, Mukta
Tracy, Adam
Roti, Giovanni
Balboni, Amanda
Vazquez, Francisca
Ligon, Keith
Piccioni, Federica
Stegmaier, Kimberly
Johannessen, Cory
Beroukhim, Rameen
NEURO-ONCOLOGY, 2017, 19 : 54 - 55
[23] Effective inhibition of MYC-amplified group 3 medulloblastoma by FACT-targeted curaxin drug CBL0137
Wang, Jiajia
Sui, Yi
Li, Qifeng
Zhao, Yang
Dong, Xiaoshu
Yang, Jian
Liang, Zhuangzhuang
Han, Yipeng
Tang, Yujie
Ma, Jie
CELL DEATH & DISEASE, 2020, 11 (12)
[24] Effective inhibition of MYC-amplified group 3 medulloblastoma by FACT-targeted curaxin drug CBL0137
Jiajia Wang
Yi Sui
Qifeng Li
Yang Zhao
Xiaoshu Dong
Jian Yang
Zhuangzhuang Liang
Yipeng Han
Yujie Tang
Jie Ma
Cell Death & Disease, 11
[25] MYC DRIVEN IMMUNE SUPPRESSION IN GROUP 3 MEDULLOBLASTOMA
Mitra, Siddhartha
Picard, Daniel
Qin, Nan
Cole, Allison
Cruz, Joselyn Cruz
Marquardt, Viktoria
Venkataraman, Sujatha
Vibhakar, Rajeev
Remke, Marc
NEURO-ONCOLOGY, 2022, 24 : 139 - 139
[26] MYC-DRIVEN UPREGULATION OF THE DE NOVO SERINE AND GLYCINE PATHWAY IS A NOVEL THERAPEUTIC TARGET FOR GROUP 3 MYC-AMPLIFIED MEDULLOBLASTOMA
Adiamah, Magretta
Lindsey, Janet C.
Burte, Florence
Kohe, Sarah
Morcavallo, Alaide
Blair, Helen
Hill, Rebecca M.
Singh, Mankaran
Crosier, Stephen
Zhang, Tong
Maddocks, Oliver
Peet, Andrew
Chesler, Louis
Hickson, Ian
Maxwell, Ross
Clifford, Steven C.
NEURO-ONCOLOGY, 2022, 24 : 125 - 125
[27] EZH2 inhibition targets B7-H3 in Myc amplified medulloblastoma
Shishido, Katherine
Venkataraman, Sujatha
Vibhakar, Rajeev
Velpula, Kiran
Asuthkar, Swapna
CANCER RESEARCH, 2022, 82 (12)
[28] Synergistic interaction of HDACi and PLK1i in Group 3 MYC-amplified medulloblastoma
Valinciute, Gintvile
Ecker, Jonas
Hielscher, Thomas
Schmidt, Christin
Remke, Marc
Sigismondo, Gianluca
Krijgsveld, Jeroen
Pfister, Stefan M.
Witt, Olaf
Milde, Till
CANCER RESEARCH, 2020, 80 (14) : 71 - 72
[29] Restoration of miR-193a expression is tumor-suppressive in MYC amplified Group 3 medulloblastoma
Harish Shrikrishna Bharambe
Annada Joshi
Kedar Yogi
Sadaf Kazi
Neelam Vishwanath Shirsat
Acta Neuropathologica Communications, 8
[30] DISSECTING REGULATORS OF THE ABERRANT POST-TRANSCRIPTIONAL LANDSCAPE IN MYC-AMPLIFIED GROUP 3 MEDULLOBLASTOMA
Kameda-Smith, Michelle
Zhu, Helen
Luo, EnChing
Venugopal, Chitra
Xella, Agata
Brown, Kevin
Fox, Raymond
Yee, Brian
Xing, Sansi
Tan, Frederick
Bakhshinyan, David
Adile, Ashley
Subapanditha, Minomi
Picard, Daniel
Moffat, Jason
Fleming, Adam
Hope, Kristin
John, Provias
Remke, Marc
Lu, Yu
Reya, Tannishitha
Reimand, Juri
Wechsler-Reya, Robert
Yeo, Gene
Singh, Sheila
NEURO-ONCOLOGY, 2020, 22 : 399 - 399

← 1 2 3 4 5 →